Next Article in Journal
Previous Article in Journal
Int. J. Mol. Sci. 2012, 13(12), 16053-16064; doi:10.3390/ijms131216053
Article

MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer

1,†
, 1,†
 and 2,*
Received: 28 August 2012; in revised form: 15 October 2012 / Accepted: 25 October 2012 / Published: 28 November 2012
(This article belongs to the Section Molecular Pathology)
View Full-Text   |   Download PDF [1102 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: MicroRNAs are noncoding RNA molecules of 18–25 nucleotides that regulate gene expression at the post-transcriptional levels. Recent data revealed that miR-218 played key roles in tumor metastasis. Here, we described the regulation and function of miR-218 in cervical cancer. Overexpression of miR-218 reduced the proliferation of the human cervical cancer cell line HeLa and induced cell apoptosis through the AKT-mTOR signaling pathway. In addition, it forced expression of miR-218 suppressed tumor growth in the orthotopic mouse model of HeLa cells. Furthermore, miR-218 increased chemosensitivity to cisplatin (CDDP) in vitro. Our results indicated that targeting miR-218 may provide a strategy for blocking the development of cervical cancer.
Keywords: miR-218; cervical cancer; HeLa; cisplatin miR-218; cervical cancer; HeLa; cisplatin
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Li, J.; Ping, Z.; Ning, H. MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer. Int. J. Mol. Sci. 2012, 13, 16053-16064.

AMA Style

Li J, Ping Z, Ning H. MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer. International Journal of Molecular Sciences. 2012; 13(12):16053-16064.

Chicago/Turabian Style

Li, Jiarui; Ping, Zhang; Ning, Hui. 2012. "MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer." Int. J. Mol. Sci. 13, no. 12: 16053-16064.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert